BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34617326)

  • 21. Mutation of Vav1 adaptor region reveals a new oncogenic activation.
    Razanadrakoto L; Cormier F; Laurienté V; Dondi E; Gardano L; Katzav S; Guittat L; Varin-Blank N
    Oncotarget; 2015 Feb; 6(4):2524-37. PubMed ID: 25426554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis of guanine nucleotide exchange mediated by the T-cell essential Vav1.
    Chrencik JE; Brooun A; Zhang H; Mathews II; Hura GL; Foster SA; Perry JJ; Streiff M; Ramage P; Widmer H; Bokoch GM; Tainer JA; Weckbecker G; Kuhn P
    J Mol Biol; 2008 Jul; 380(5):828-43. PubMed ID: 18589439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The N-terminal 20-amino acid region of guanine nucleotide exchange factor Vav1 plays a distinguished role in T cell receptor-mediated calcium signaling.
    Li SY; Du MJ; Wan YJ; Lan B; Liu YH; Yang Y; Zhang CZ; Cao Y
    J Biol Chem; 2013 Feb; 288(6):3777-85. PubMed ID: 23271736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Regulatory effect of Vav1 on T cells and its relation to clinical diseases].
    Zhang Y; Chen W
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 47(1):75-81. PubMed ID: 30146815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vav1 Promotes B-Cell Lymphoma Development.
    Shalom B; Farago M; Salaymeh Y; Sebban S; Pikarsky E; Katzav S
    Cells; 2022 Mar; 11(6):. PubMed ID: 35326399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genetic alterations in new category of Peripheral T-cell lymphoma, not otherwise specified].
    Fukumoto K
    Rinsho Ketsueki; 2022; 63(12):1657-1667. PubMed ID: 36653140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Natural Variant of the Signaling Molecule Vav1 Enhances Susceptibility to Myasthenia Gravis and Influences the T Cell Receptor Repertoire.
    Bernard I; Sacquin A; Kassem S; Benamar M; Colacios C; Gador M; Pérals C; Fazilleau N; Saoudi A
    Front Immunol; 2018; 9():2399. PubMed ID: 30410484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vav1 couples the T cell receptor to cAMP response element activation via a PKC-dependent pathway.
    Haubert D; Weckbecker G
    Cell Signal; 2010 Jun; 22(6):944-54. PubMed ID: 20138987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lineage-specific requirement for the PH domain of Vav1 in the activation of CD4+ but not CD8+ T cells.
    Prisco A; Vanes L; Ruf S; Trigueros C; Tybulewicz VL
    Immunity; 2005 Sep; 23(3):263-74. PubMed ID: 16169499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A guanine nucleotide exchange factor-independent function of Vav1 in transcriptional activation.
    Kuhne MR; Ku G; Weiss A
    J Biol Chem; 2000 Jan; 275(3):2185-90. PubMed ID: 10636924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of knockout mice reveals a synergistic role of the Vav1 and Rasgrf2 gene deficiencies in lymphomagenesis and metastasis.
    Ruiz S; Santos E; Bustelo XR
    PLoS One; 2009 Dec; 4(12):e8229. PubMed ID: 20011522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indoleamine 2,3-dioxygenase regulates T cell activity through Vav1/Rac pathway.
    Li R; Li H; Sun Q; Liu L; Zhang C; Ren X
    Mol Immunol; 2017 Jan; 81():102-107. PubMed ID: 27930920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulus-dependent regulation of the phagocyte NADPH oxidase by a VAV1, Rac1, and PAK1 signaling axis.
    Roepstorff K; Rasmussen I; Sawada M; Cudre-Maroux C; Salmon P; Bokoch G; van Deurs B; Vilhardt F
    J Biol Chem; 2008 Mar; 283(12):7983-93. PubMed ID: 18160398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vav2 pharmaco-mimetic mice reveal the therapeutic value and caveats of the catalytic inactivation of a Rho exchange factor.
    Lorenzo-Martín LF; Rodríguez-Fdez S; Fabbiano S; Abad A; García-Macías MC; Dosil M; Cuadrado M; Robles-Valero J; Bustelo XR
    Oncogene; 2020 Jul; 39(28):5098-5111. PubMed ID: 32528129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positive regulation of Vav1 by Themis controls CD4 T cell pathogenicity in a mouse model of central nervous system inflammation.
    Marrocco R; Bernard I; Joulia E; Barascud R; Dejean AS; Lesourne R; Saoudi A
    Cell Mol Life Sci; 2024 Apr; 81(1):161. PubMed ID: 38565808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokine-induced Zap70 kinase-mediated dissociation of the Vav1-talin complex activates alpha4beta1 integrin for T cell adhesion.
    García-Bernal D; Parmo-Cabañas M; Dios-Esponera A; Samaniego R; Hernán-P de la Ossa D; Teixidó J
    Immunity; 2009 Dec; 31(6):953-64. PubMed ID: 20005136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vav2 lacks Ca
    Fray MA; Charpentier JC; Sylvain NR; Seminario MC; Bunnell SC
    J Cell Sci; 2020 Mar; 133(5):. PubMed ID: 31974114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice.
    Salaymeh Y; Farago M; Sebban S; Shalom B; Pikarsky E; Katzav S
    Life Sci Alliance; 2020 May; 3(5):. PubMed ID: 32277014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studying the dynamics of SLP-76, Nck, and Vav1 multimolecular complex formation in live human cells with triple-color FRET.
    Pauker MH; Hassan N; Noy E; Reicher B; Barda-Saad M
    Sci Signal; 2012 Apr; 5(221):rs3. PubMed ID: 22534133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signal-transducing adaptor protein-2 regulates stromal cell-derived factor-1 alpha-induced chemotaxis in T cells.
    Sekine Y; Ikeda O; Tsuji S; Yamamoto C; Muromoto R; Nanbo A; Oritani K; Yoshimura A; Matsuda T
    J Immunol; 2009 Dec; 183(12):7966-74. PubMed ID: 19933863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.